Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter and six months period ended 30 September 2026

27 October 2026 To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra - Kurla Complex, Mumbai 400 001 Bandra (E), Mumbai 400 051 Scrip Code: 524669 Symbol: HESTERBIO Dear Sir / Madam: Subject: Intimation for the Board Meeting This is to inform you that, as per Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended from time to time), a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 5 November 2026, inter alia, to consider the unaudited standalone and consolidated financial results of the Company for the quarter and six months period ended 30 September 2026. We request you to take note of the above. Sincerely For Hester Biosciences Limited Vinod Mali Company Secretary & Compliance Officer